Presentation 12-Month Results From First-in-Human Randomized Study of Ranger DCB for Femoropopliteal Treatment May 08, 2018
Presentation ACC 2018 High Rate of Amputation and Death after Major Adverse Limb Events (MALE) in Peripheral Artery Disease: Results from COMPASS Presenter: Sonia S. Anand March 11, 2018
Presentation VIVA 2017 Two-year Results from the IN.PACT Global Study Presenter: Thomas Zeller September 14, 2017
Presentation VIVA 2017 Paclitaxel-Eluting Stent Treatment for PAD: Insights from the Zilver PTX Post-Market Study in Japan Presenter: Michael Dake September 14, 2017
Presentation CCVVC 2016 Use of Drug Eluting Stents in the SFA: What are the Current Data, Real World Applications, Upcoming Trials Presenter: Tyrone Collins June 15, 2016
Presentation CCVVC 2016 My most difficult femoropopliteal case: 69 yo female Presenter: Jos C. van den Berg June 15, 2016
Presentation CCVVC 2016 My Most Difficult Femoropopliteal Case Presenter: Fabrizio Fanelli June 15, 2016
Presentation Aortovascular 2015 The Antiproliferative Endovascular Era in PAD Treatment: Are we there yet? Presenter: Danielle R. Bajakian September 18, 2015
Presentation CICT 2015 Drug Eluting Femoral Stents Where does it fit in my practice? Presenter: Yazan Khatib July 31, 2015
Presentation CCVVC 2015 Future Therapeutic Options in the Management of CLI Presenter: D. Scheinert June 18, 2015
Presentation ISET 2015 Recanalization of SFA Popliteal Arteries: Flossing and Other Solutions Presenter: Alan H. Matsumoto February 02, 2015
Presentation ISET 2015 New Insights from Real-World Femoral-Popliteal Drug-Coated Balloon Treatment: One-Year Results from IN_PACT Global Study, Including Long Lesions Presenter: Gunnar Tepe February 02, 2015
Presentation ISET 2015 Achieving Re-entry in the Femoral Popliteal Segment Presenter: Robert Lookstein January 30, 2015
Presentation DCB vs Standard PTA for the Treatment of Superficial Femoral and-or Popliteal PAD Presenter: G. Tepe December 15, 2014
Presentation TCT 2014 TCT 530: Effectiveness of the Misago Stent for the Treatment of Superficial Femoral Artery Disease: 12-Month Results of the First Japan and the United States Collaboration Trial (OSPREY) Presenter: Lawrence A. Garcia, Richard M. Green, Douglas E. Drachman, Takao Ohki, MD September 14, 2014
Presentation TCT 2014 Endovascular Approaches to Common Femoral Artery Obstructive Disease: Finally Ready for Primetime? Presenter: Robert M. Bersin, Dierk Scheinert, Roger Gammon, Thomas Zeller September 13, 2014
Presentation SMART Nitinol Self-expanding Stent in the Treatment of Obstructive Superficial Femoral Artery Disease Presenter: Michael R. Jaff January 20, 2014
Presentation TCT 2013 Increased Local Cytokine Production at Culprit Superficial Femoral Artery Plaques Presenter: Cameron Donaldson, David Schneider, Daniel Bertges, Julie Adams, Nader Elgharib, Ellie Mueller, William Prabhu, Taka Ashikaga, Amy Henderson, Harold Dauerman January 31, 2013
Presentation TCT 2013 Evaluation of Long-term Vascular Responses to Fluorocopolymer coated Self-Expanding low-dose Paclitaxel-eluting Stent in Porcine Ilio-femoral Model Presenter: Dongming Hou, Barbara Huibregtse, William Stoffregen, Gordon Kocur, Cory Hitzman, Elizabeth Stejskal, John Heil, Keith Dawkins January 31, 2013